1. Reassessing the Relevance of Pharmacoeconomic Analyses in Formulary Decisions

   • Jeffrey A. Johnson
   • Erwin Friesen

   Current Opinion 16 September 2012 Pages: 479 - 485

2. The Use of the Bootstrap Statistical Method for the Pharmacoeconomic Cost Analysis of Skewed Data

   • Alain Desgagné
   • Anne-Marie Castilloux
   • Jacques Le Lorier

   Leading Article 16 September 2012 Pages: 487 - 497

3. Should Antibacterials Be Deregulated?

   • Joan Rovira
   • Montserrat Figueras
   • Josep L. Segú

   Leading Article 16 September 2012 Pages: 499 - 508

4. Economic Analysis of Fluconazole versus Amphotericin B for the Treatment of Candidemia in Non-Neutropenic Patients

   • George Dranitsaris
   • Peter Phillips
   • Steve Ioannou

   Original Research Article 16 September 2012 Pages: 509 - 518

5. Predicting Hospitalisation of Patients with Diabetes Mellitus

   • Samir K. Bhattacharyya

   Original Research Article 16 September 2012 Pages: 519 - 529

6. Linking the Health Utilities Index to National Medical Expenditure Survey Data

   • John A. Rizzo
   • Steven Pashko
   • Jody L. Sindelar

   Original Research Article 16 September 2012 Pages: 531 - 541

7. Fluoxetine

   • Michelle I. Wilde
   • Paul Benfield

   Adis Pharmacoeconomic Drug Evaluation 16 September 2012 Pages: 543 - 561

8. How to Calculate Indirect Costs in Economic Evaluations

   • Werner B. F. Brouwer
   • Marc A. Koopmanschap

   Correspondence 16 September 2012 Pages: 563 - 566

9. Correspondence

   • Bengt Liljas

   Correspondence 16 September 2012 Pages: 566 - 569

10. Cost Analysis of the Treatment of Schizophrenia in the UK

    • Stephen Almond
    • Owen O’ Donnell

    Original Research Article 16 September 2012 Pages: 575 - 588

11. Assessing the Willingness of Parents to Pay for Reducing Postoperative Emesis in Children

    • Lara Diez

    Original Research Article 16 September 2012 Pages: 589 - 595

12. The Economic Cost of Multiple Sclerosis in Sweden in 1994

    • Freddie Henriksson
    • Bengt Jönsson

    Original Research Article 16 September 2012 Pages: 597 - 606

13. Economic Evaluation of Multiple Sclerosis in the UK, Germany and France

    • Nuala Murphy
    • C. Confavreux
    • J. -L. Mérot

    Original Research Article 16 September 2012 Pages: 607 - 622

14. Cost-Effectiveness Analysis of Treatments to Reduce Cholesterol Levels, Blood Pressure and Smoking for the Prevention of Coronary Heart Disease

    • Pedro Plans-Rubió

    Original Research Article 16 September 2012 Pages: 623 - 643

15. Cost Effectiveness of Early Treatment with Oral Aciclovir in Adult Chickenpox

    • Kenneth J. Smith
    • Mark S. Roberts

    Original Research Article 16 September 2012 Pages: 645 - 651